Japanese scientist operates on lean budget

Shinya Yamanaka shook the stem cell research field with his work taking adult skin cells and turning them into embryonic stem cells. The key was identifying 24 genes that were the odds-on favorite for reprogramming the cell and then narrowing it to four that worked. In an interview with the Wall Street Journal, Yamanaka discusses how he operates a barebones lab on a million dollars a year, marveling at the billions of dollars that are spent in the U.S. Researchers in Japan, he says, are lone wolves. And he notes that ESC research is widely understood in the U.S., but barely registers on the Japanese psyche.

- read the report from The Wall Street Journal (sub. req.)

Related Article:
Adult stem cell prototype on the horizon. Report

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.